Sign In
Buy INVVY
$21.85
+0 (+0%)
At Close: Sep 08, 2023
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
08:30pm, Thursday, 12'th Mar 2026
RICHMOND, Va., March 12, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced the pricing of its offering of $450,000,000 aggregate principal amount of 0.625% convert
Indivior Announces Proposed Convertible Senior Notes Offering
07:00am, Thursday, 12'th Mar 2026
RICHMOND, Va., March 12, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate p
Indivior Pharmaceuticals, Inc. (INDV) Q4 2025 Earnings Call Transcript
06:28pm, Thursday, 26'th Feb 2026
Indivior Pharmaceuticals, Inc. (INDV) Q4 2025 Earnings Call Transcript
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
07:00am, Thursday, 26'th Feb 2026
RICHMOND, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today reported its financial results for the fourth quarter and full year ended December 31, 2025, and p
Indivior to Participate in Upcoming Investor Conferences
07:00am, Tuesday, 24'th Feb 2026
RICHMOND, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will participate in the following upcoming investor conferences: Barclays 28th An
Indivior (OTCMKTS:INVVY) Stock Crosses Below Fifty Day Moving Average – Here’s Why
04:18am, Wednesday, 11'th Feb 2026
Indivior PLC (OTCMKTS:INVVY - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $21.85 and traded as low as $21
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
07:00am, Wednesday, 28'th Jan 2026
RICHMOND, Va., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its fourth quarter and full-year 2025 financial results on Thursday,
Indivior Announces Completion of Redomiciliation to the United States
07:00am, Monday, 26'th Jan 2026
RICHMOND, Va., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), today announced completion of its redomiciliation from the United Kingdom to the United States.
Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus
09:46am, Monday, 12'th Jan 2026
Zacks highlights how Indivior, FIGS and Ulta Beauty delivered outsized gains as its ranks, recommendations and focus lists beat a volatile market.
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
07:00am, Thursday, 08'th Jan 2026
Total Net Revenue Expected in the Range of $1,125 million to $1,195 million Total SUBLOCADE ® Net Revenue Expected to be in the Range of $905 million to $945 million Non-GAAP Operating Expenses Exp
Antibe Therapeutics (OTCMKTS:ATBPD) and Indivior (OTCMKTS:INVVY) Head to Head Review
02:00am, Saturday, 27'th Dec 2025
Risk and Volatility Antibe Therapeutics has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Indivior has a beta of 0.35, meaning that its stock price
Indivior Announces Inclusion in the S&P SmallCap 600® Index
07:00am, Monday, 22'nd Dec 2025
RICHMOND, Va. , Dec. 22, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("Indivior PLC" or the "Company") today announced that it will be added to the S&P SmallCap 600® index, effective today.
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge
09:30am, Sunday, 07'th Dec 2025
New York City-based Newtyn Management increased its stake in Indivior by nearly 1.6 million shares in the third quarter, resulting in a net position change of $62.8 million. The transaction represents
Indivior Concludes Legacy U.S. Department of Justice Matter
04:01pm, Thursday, 20'th Nov 2025
RICHMOND, Va. , Nov. 20, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced the Company has concluded the legacy U.S. Department of Justice (DOJ) matter by paying in full the outstandin
Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference
09:21am, Wednesday, 19'th Nov 2025
RICHMOND, Va. , Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37th Annual Healthcare Conference: Piper Sandler 37th Annual H
